Time Restricted Eating Plus Exercise for Weight Management
NCT ID: NCT05290233
Last Updated: 2024-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2023-09-21
2024-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TRE With Physical Activity for Weight Management
NCT04978376
Time Restricted Feeding for Weight Loss and Cardio-protection
NCT02948517
Time Restricted Eating for Weight Management
NCT04692532
Time Restricted Feeding (4-hour Versus 6-hour) for Weight Loss in Obese Adults
NCT03867773
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults
NCT03459703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRE+RT
Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised resistance training per week.
TRE + Exercise
We will compare the effects of TRE combined with resistance exercise versus TRE combined with aerobic training.
Other Names:
resistance training endurance exercise
TRE+AT
Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised aerobic training per week.
TRE + Exercise
We will compare the effects of TRE combined with resistance exercise versus TRE combined with aerobic training.
Other Names:
resistance training endurance exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TRE + Exercise
We will compare the effects of TRE combined with resistance exercise versus TRE combined with aerobic training.
Other Names:
resistance training endurance exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pre-diabetes (fasting glucose: 100-125 mg/dl or HBA1c 5.7%-6.4% or OGTT ≥ 200 mg/dl)
* sedentary or lightly active (\<7,500 steps/day)
* between the ages of 50-80 years
Exclusion Criteria
* HbA1c: \>6.5%)
* Individuals with a history of eating disorders
* shift workers
* Individuals taking drugs to control body weight and glucose (including metformin)
* individuals who are not weight stable (weight gain or loss \> 4 kg) 3 months prior to the intervention
* mobility disorders or individuals unable to exercise for 40-60 minutes 3-4 days/week
* Individuals diagnosed with comorbidities impacting cognition, including major/mild neurocognitive disorder, cerebrovascular disease (e.g., stroke, aneurysm, arteriovenous malformation), traumatic brain injury, epilepsy, or major psychiatric disorder (e.g., schizophrenia, bipolar disorder, substance use disorder)
* Individuals who are unable to adequately report dietary intake or physical activity
* Smokers
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelsey Nicole Dipman Gabel
Clinical Assistant Professor and Postdoctoral Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois at Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.